Skip to main navigation
Skip to search
Skip to main content
Creighton University Home
Home
Profiles
Research Units
Projects
Research output
Search by expertise, name or affiliation
New treatment options in COPD.
Daniel E. Hilleman
Department of Pharmacy Practice
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New treatment options in COPD.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Bronchodilator Agents
48%
Chronic Obstructive Pulmonary Disease
50%
Clinical Trials
9%
Dyspnea
12%
Fluticasone-Salmeterol Drug Combination
65%
Guidelines
9%
Ipratropium
20%
Maintenance
9%
Patient Compliance
13%
Placebos
9%
Quality of Life
18%
Salmeterol Xinafoate
20%
Therapeutics
9%
Tiotropium Bromide
63%
Treatment Adherence and Compliance
16%
Chemical Compounds
Fluticasone
84%
Ipratropium
28%
Once Daily
23%
Salmeterol
100%
Tiotropium
84%
Social Sciences
Clinical Trials
14%
Global initiatives
20%
quality of life
22%